Biomolecular condensates in cancer biology
- PMID: 34865286
- PMCID: PMC8819300
- DOI: 10.1111/cas.15232
Biomolecular condensates in cancer biology
Abstract
Understanding the characteristics of cancer cells is essential for the development of improved diagnosis and therapeutics. From a gene regulation perspective, the super-enhancer concept has been introduced to systematically understand the molecular mechanisms underlying the identities of various cell types and has been extended to the analysis of cancer cells and cancer genome alterations. In addition, several characteristic features of super-enhancers have led to the recognition of the link between gene regulation and biomolecular condensates, which is often mediated by liquid-liquid phase separation. Several lines of evidence have suggested molecular and biophysical principles and their alterations in cancer cells, which are particularly associated with gene regulation and cell signaling (" transcriptional" and "signaling" condensates). These findings collectively suggest that the modification of biomolecular condensates represents an important mechanism by which cancer cells acquire various cancer hallmark traits and establish functional innovation for cancer initiation and progression. The condensate model also provides the molecular basis of the vulnerability of cancer cells to transcriptional perturbation and further suggests the possibility of therapeutic targeting of condensates. This review summarizes recent findings regarding the relationships between super-enhancers and biomolecular condensate models, multiple scenarios of condensate alterations in cancers, and the potential of the condensate model for therapeutic development.
Keywords: biomolecular condensate; cancer; intrinsically disordered region; liquid-liquid phase separation; super-enhancer.
© 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.
Figures




Similar articles
-
Conformational Dynamics of Intrinsically Disordered Proteins Regulate Biomolecular Condensate Chemistry.Chem Rev. 2022 Mar 23;122(6):6719-6748. doi: 10.1021/acs.chemrev.1c00774. Epub 2022 Feb 18. Chem Rev. 2022. PMID: 35179885 Free PMC article. Review.
-
Biomolecular condensates: A new lens on cancer biology.Biochim Biophys Acta Rev Cancer. 2025 Feb;1880(1):189245. doi: 10.1016/j.bbcan.2024.189245. Epub 2024 Dec 13. Biochim Biophys Acta Rev Cancer. 2025. PMID: 39675392 Review.
-
Recent advances in engineering synthetic biomolecular condensates.Biotechnol Adv. 2024 Dec;77:108452. doi: 10.1016/j.biotechadv.2024.108452. Epub 2024 Sep 11. Biotechnol Adv. 2024. PMID: 39271032 Review.
-
Spatial genome organization, TGFβ, and biomolecular condensates: Do they talk during development?Bioessays. 2022 Dec;44(12):e2200145. doi: 10.1002/bies.202200145. Epub 2022 Oct 17. Bioessays. 2022. PMID: 36253122 Review.
-
Liquid condensates: a new barrier to loop extrusion?Cell Mol Life Sci. 2025 Feb 20;82(1):80. doi: 10.1007/s00018-024-05559-8. Cell Mol Life Sci. 2025. PMID: 39976773 Free PMC article. Review.
Cited by
-
ASCL1 regulates super-enhancer-associated miRNAs to define molecular subtypes of small cell lung cancer.Cancer Sci. 2022 Nov;113(11):3932-3946. doi: 10.1111/cas.15481. Epub 2022 Aug 30. Cancer Sci. 2022. PMID: 35789143 Free PMC article.
-
CCR8 antagonist suppresses liver cancer progression via turning tumor-infiltrating Tregs into less immunosuppressive phenotype.J Exp Clin Cancer Res. 2025 Apr 4;44(1):113. doi: 10.1186/s13046-025-03286-x. J Exp Clin Cancer Res. 2025. PMID: 40186298 Free PMC article.
-
Methylene blue accelerates liquid-to-gel transition of tau condensates impacting tau function and pathology.Nat Commun. 2023 Sep 6;14(1):5444. doi: 10.1038/s41467-023-41241-6. Nat Commun. 2023. PMID: 37673952 Free PMC article.
-
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer.Cancer Sci. 2024 Apr;115(4):1283-1295. doi: 10.1111/cas.16104. Epub 2024 Feb 13. Cancer Sci. 2024. PMID: 38348576 Free PMC article.
-
The molecular understanding of super-enhancer dysregulation in cancer.Nagoya J Med Sci. 2022 May;84(2):216-229. doi: 10.18999/nagjms.84.2.216. Nagoya J Med Sci. 2022. PMID: 35967935 Free PMC article. Review.
References
-
- Blobel GA, Higgs DR, Mitchell JA, Notani D, Young RA. Testing the super‐enhancer concept. Nat Rev Genet. 2021;22(12):749‐755. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical